Literature DB >> 2861190

Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.

G Zackrisson, J E Brorson, B Björnegård, B Trollfors.   

Abstract

The susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem (N-formimidoyl-thienamycin), mecillinam and rifampicin was studied by agar and broth dilution. There were discrepancies between MICs registered on solid medium and in fluid medium. There seems to be a need for methodological studies on the antibiotic susceptibility of Bord. pertussis using different techniques. None of the compounds tested seemed to be realistic alternatives to the well documented erythromycin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861190     DOI: 10.1093/jac/15.5.629

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Emergence of quinolone-resistant Bordetella pertussis in Japan.

Authors:  Masayuki Ohtsuka; Ken Kikuchi; Kenichiro Shimizu; Namiko Takahashi; Yuka Ono; Takashi Sasaki; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

3.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Authors:  J E Hoppe; A Bryskier
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation.

Authors:  H Ishikawa; Y Isayama; K Ohmae
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 6.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

7.  Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; T Tschirner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.

Authors:  Lijun Li; Jikui Deng; Xiang Ma; Kai Zhou; Qinghong Meng; Lin Yuan; Wei Shi; Qing Wang; Yue Li; Kaihu Yao
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.